Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Levothyroxine is the synthetic levo-isomer form of thyroxine (T4), a principal hormone produced by the thyroid gland. It functions as a prohormone for triiodothyronine (T3), its more active metabolite, and is essential for normal metabolism, growth, and neurological development. Levothyroxine is used primarily as a replacement therapy in hypothyroidism (both congenital and acquired), as well as for thyrotropin suppression in certain thyroid cancers. It does not act as a receptor, enzyme, or transporter, but replaces natural hormone and exerts effects via conversion to T3 and activation of nuclear thyroid hormone receptors. It is one of the most prescribed medications worldwide, though inappropriate use and over-replacement can pose significant health risks[1][2][3][4][5][6].
Thyroxine (T4) is a prohormone that is converted to triiodothyronine (T3), the active form. T3 binds to nuclear thyroid hormone receptors to regulate gene transcription and protein synthesis, leading to increased metabolic rate, oxygen consumption, and energy use[1][3][5].
10 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Thyroxine (T4) (T4).